SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006628
Filing Date
2018-08-07
Accepted
2018-08-07 17:00:01
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20180630x10q.htm 10-Q 2417147
2 EX-10.5 vygr-20180630ex1059d9d1c.htm EX-10.5 79203
3 EX-31.1 vygr-20180630ex3112a67e3.htm EX-31.1 20040
4 EX-31.2 vygr-20180630ex312784d87.htm EX-31.2 20044
5 EX-32.1 vygr-20180630ex32132f487.htm EX-32.1 15389
6 GRAPHIC vygr20180630x10q001.jpg GRAPHIC 78059
  Complete submission text file 0001558370-18-006628.txt   8268446

Data Files

Seq Description Document Type Size
7 EX-101.INS vygr-20180630.xml EX-101.INS 1766093
8 EX-101.SCH vygr-20180630.xsd EX-101.SCH 55565
9 EX-101.CAL vygr-20180630_cal.xml EX-101.CAL 54982
10 EX-101.DEF vygr-20180630_def.xml EX-101.DEF 204894
11 EX-101.LAB vygr-20180630_lab.xml EX-101.LAB 434159
12 EX-101.PRE vygr-20180630_pre.xml EX-101.PRE 340546
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 18998873
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences